Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Phase 1 Study Evaluating the Safety and Tolerability of HMPL-760 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Other Non-Hodgkin Lymphoma (NHL)

NCT05176691 is registered in ClinicalTrials.gov with Hutchmed as lead sponsor.

NCT NCT05176691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05176691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Phase 1 Study Evaluating the Safety and Tolerability of HMPL-760 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Other Non-Hodgkin Lymphoma (NHL)
Lead sponsor
Hutchmed
Phase
Phase 1
Overall status
Withdrawn
Start date
February 15, 2022
Completion date
November 16, 2022
Enrollment
0 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cll/sll, dlbcl, follicular lymphoma, lymphoplasmacytic lymphoma, mcl, mzl, nhl, richter syndrome, waldenstrom macroglobulinemia